EUVIMEDEUVIMED entdecken
Crossref

Fusion of IgG antibodies to albumin inhibits transport across the placenta

Jeannette Nilsen iD, Kine M K Sand iD, Hana J Al-Khabbaz iD, Lennart Maximilian van Ligtenberg iD, Simone Mester iD, Line Mathiesen iD, Hanna T Noordzij iD, Kjell-Rune Jensen iD, Nils Leitzinger iD, Oda Ottersen, Sopisa Benjakul iD, Marie Leangen Herigstad iD und 16 weitere

Science Immunology · 14.08.2026 · 11 (122)

DOI: 10.1126/sciimmunol.aee5151 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Immunology, erschienen am 14.08.2026. Verfasst von Jeannette Nilsen und 27 weiteren Autor:innen. Beteiligte Einrichtung: Precision Immunotherapy Alliance (PRIMA), University of Oslo, Oslo, Norway. Hauptthemen laut MEDLINE: Placenta, Immunoglobulin G, Albumins, Recombinant Fusion Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 115 Literaturangaben. Gefördert von: National Institutes of Health, Norges Forskningsråd, South-Eastern Norway Regional Health Authority.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunoglobulin G (IgG)–based monoclonal antibodies are effective therapies for cancer, autoimmune diseases, and migraine. However, they are actively transported across the placenta by the neonatal Fc receptor (FcRn), limiting their use during pregnancy. Using mouse models and an ex vivo human placental perfusion system, we show that although FcRn binds albumin independently of IgG, albumin is not transported to the fetus in mice or across human placental tissue. Fusion of IgG to albumin markedly reduced transplacental transport in both models while preserving the prolonged plasma half-life conferred by FcRn. Similarly, fragment antigen–binding fragments fused to engineered albumin with enhanced FcRn binding showed minimal fetal exposure. In a mouse model of fetal and neonatal alloimmune thrombocytopenia, albumin fusion of an anti–human platelet antigen IgG reduced fetal antibody transfer and attenuated thrombocytopenia in the offspring. These findings identify albumin as an attractive fusion partner for biologics intended to minimize fetal exposure during pregnancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PlacentaImmunoglobulin GAlbuminsRecombinant Fusion ProteinsAnimalsFemalePregnancyHumansReceptors, FcMiceHistocompatibility Antigens Class IMaternal-Fetal ExchangeMice, Inbred C57BLThrombocytopenia, Neonatal Alloimmune

Substanzen

Receptors, FcImmunoglobulin GFc receptor, neonatalHistocompatibility Antigens Class IAlbuminsRecombinant Fusion Proteins

Autor:innen und Institutionen

  • Precision Immunotherapy Alliance (PRIMA), University of Oslo, Oslo, Norway.
  • Institute of Clinical Medicine and Department of Pharmacology, University of Oslo and Oslo University Hospital, Oslo, Norway.
  • Department of Immunology, University of Oslo and Oslo University Hospital, Rikshospitalet, Oslo, Norway.
  • College of Pharmacy, Riyadh Elm University, Riyadh, Saudi Arabia.
  • Jackson Laboratory, Bar Harbor, ME, USA.
  • Immunology Research Group, Department of Medical Biology, Faculty of Health Sciences, UiT the Arctic University of Norway, Tromsø, Norway.

ORCID-Profile: Jeannette Nilsen, Kine M K Sand, Hana J Al-Khabbaz, Lennart Maximilian van Ligtenberg, Simone Mester, Line Mathiesen, Hanna T Noordzij, Kjell-Rune Jensen, Nils Leitzinger, Sopisa Benjakul, Marie Leangen Herigstad, Fulgencio Ruso-Julve, Aina Karen Anthi, Mari Nyquist-Andersen, Torleif Tollefsrud Gjølberg, Eirin Listau Bertelsen, Stian Foss, Gregory J Christianson, Tilman Schlothauer, Tor Brynjar Stuge, Lisbeth E Knudsen, Inger Sandlie, Derry C Roopenian, Maria Therese Ahlen, Jan Terje Andersen

Förderung

  • National Institutes of Health
  • Norges Forskningsråd
  • South-Eastern Norway Regional Health Authority
  • North Norway Regional Health Authority
  • Saudi Ministry of Education - King Abdullah Scholarship

Zitieren

APA

Nilsen, J., Sand, K. M. K., Al-Khabbaz, H. J., van Ligtenberg, L. M., Mester, S., Mathiesen, L., Noordzij, H. T., Jensen, K. R., Leitzinger, N., Ottersen, O., Benjakul, S., Herigstad, M. L., Ruso-Julve, F., Anthi, A. K., Moen, A., Nyquist-Andersen, M., Gjølberg, T. T., Bertelsen, E. L., Cameron, J., …, & Andersen, J. T. (2026). Fusion of IgG antibodies to albumin inhibits transport across the placenta. Science Immunology, 11(122). https://doi.org/10.1126/sciimmunol.aee5151

Vancouver

Nilsen J, Sand KMK, Al-Khabbaz HJ, van Ligtenberg LM, Mester S, Mathiesen L, et al. Fusion of IgG antibodies to albumin inhibits transport across the placenta. Science Immunology. 2026;11(122). doi:10.1126/sciimmunol.aee5151

BibTeX
@article{Nilsen2026,
  author = {Nilsen, Jeannette and Sand, Kine M K and Al-Khabbaz, Hana J and van Ligtenberg, Lennart Maximilian and Mester, Simone and Mathiesen, Line and Noordzij, Hanna T and Jensen, Kjell-Rune and Leitzinger, Nils and Ottersen, Oda and Benjakul, Sopisa and Herigstad, Marie Leangen and Ruso-Julve, Fulgencio and Anthi, Aina Karen and Moen, Anders and Nyquist-Andersen, Mari and Gjølberg, Torleif Tollefsrud and Bertelsen, Eirin Listau and Cameron, Jason and Foss, Stian and Christianson, Gregory J and Schlothauer, Tilman and Stuge, Tor Brynjar and Knudsen, Lisbeth E and Sandlie, Inger and Roopenian, Derry C and Ahlen, Maria Therese and Andersen, Jan Terje},
  title = {Fusion of IgG antibodies to albumin inhibits transport across the placenta},
  journal = {Science Immunology},
  year = {2026},
  volume = {11},
  number = {122},
  doi = {10.1126/sciimmunol.aee5151}
}
Kostenlos starten →